Gemphire Therapeutics Announces Departure of Its Chief Executive Officer Mina Sooch

LIVONIA, Mich., May 30, 2017 (GLOBE NEWSWIRE) — Gemphire Therapeutics Inc. (GEMP) announced today that Mina Sooch, President, CEO, and Director of the Company has resigned for personal reasons effective May 23, 2017.  Dr. Steven Gullans, a member of the Gemphire Therapeutics Board of Directors, has been named Interim President and Chief Executive Officer until a search for his replacement is completed.